Stay updated on Tempol (MBM-02) in COVID-19 Patients Clinical Trial
Sign up to get notified when there's something new on the Tempol (MBM-02) in COVID-19 Patients Clinical Trial page.

Latest updates to the Tempol (MBM-02) in COVID-19 Patients Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2; no user-visible changes to the study details or page layout were detected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoChange DetectedDeletion of the government funding notice about potential delays in website updates and responses. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check33 days agoChange DetectedThe screenshots show the same study page with no substantive changes to core content.SummaryDifference0.4%

- Check62 days agoChange Detected- Updated the page to include a government-operating-status notice and a new version tag (v3.2.0), replacing the old v3.1.0.SummaryDifference4%

- Check69 days agoChange DetectedApparent page reversion to a new version (v3.1.0) while removing several drug-safety and drug-category topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs), indicating content consolidation.SummaryDifference0.5%

- Check83 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2, with the Back to Top element removed; no other substantive changes.SummaryDifference0.2%

Stay in the know with updates to Tempol (MBM-02) in COVID-19 Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tempol (MBM-02) in COVID-19 Patients Clinical Trial page.